Related Experiment Video
Updated: Feb 10, 2026
08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
8.4K
BCL-2 as therapeutic target for hematological malignancies
Guilherme Fleury Perini1, Glaciano Nogueira Ribeiro2, Jorge Vaz Pinto Neto3
1Hospital Israelita Albert Einstein, Av. Albert Einstein, 627, Sao Paulo, Sao Paulo, 05652-900, Brazil.
Journal of Hematology & Oncology
|May 12, 2018
Summary
Dysregulation of cell death, particularly BCL-2 upregulation, drives cancer. BH3-mimetics like venetoclax offer a targeted therapy for hematological malignancies, showing promise in treating chronic lymphocytic leukemia (CLL).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Cancer development involves disrupted cell proliferation and death balance.
- Increased apoptosis resistance, often due to BCL-2 upregulation, is crucial in hematological malignancies.
- BCL-2, the first identified apoptosis modulator, is a key factor in cancer progression and treatment resistance.
Purpose of the Study:
- To review the role of BCL-2 in apoptosis at the mitochondrial level.
- To explore BCL-2 as a therapeutic target for hematological cancers.
- To summarize outcomes of BH3-mimetic inhibitors, particularly venetoclax, in treating these malignancies.
Main Methods:
- Literature review focusing on BCL-2 function and targeted therapies.
- Analysis of clinical data for BH3-mimetics, especially venetoclax.
- Discussion of venetoclax in monotherapy and combination treatments.
Main Results:
- BH3-mimetics, including venetoclax, demonstrate efficacy in targeting BCL-2.
- Venetoclax is approved for chronic lymphocytic leukemia (CLL) with 17p deletion.
- Positive clinical results are observed with venetoclax, both alone and combined with other agents.
Conclusions:
- BCL-2 is a critical regulator of apoptosis and a viable therapeutic target in hematological cancers.
- Selective BCL-2 inhibitors like venetoclax represent a significant advancement in cancer treatment.
- Further research into combination therapies may enhance treatment outcomes for patients with hematological malignancies.
Related Concept Videos
01:13Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
01:30Therapeutic Communication
8.6K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.6K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
01:13meta-Directing Deactivators: –NO2, –CN, –CHO, –CO2R, –COR, –CO2H
6.7K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.7K
01:30Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K